Insufficient scRNA-seq data for expression of PEAK3 at single-cell level.
Insufficient scRNA-seq data for expression of PEAK3 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 87% | 30.50 | 2290 / 2642 | 73% | 2.20 | 513 / 705 |
stomach | 89% | 39.26 | 318 / 359 | 45% | 0.89 | 130 / 286 |
lung | 99% | 163.07 | 573 / 578 | 34% | 0.62 | 398 / 1155 |
kidney | 82% | 43.66 | 73 / 89 | 47% | 0.99 | 427 / 901 |
esophagus | 83% | 37.49 | 1206 / 1445 | 42% | 0.68 | 76 / 183 |
intestine | 91% | 57.06 | 882 / 966 | 32% | 0.56 | 168 / 527 |
bladder | 95% | 38.43 | 20 / 21 | 19% | 0.33 | 97 / 504 |
breast | 92% | 42.22 | 423 / 459 | 19% | 0.31 | 214 / 1118 |
prostate | 95% | 51.31 | 233 / 245 | 14% | 0.18 | 68 / 502 |
adrenal gland | 97% | 57.12 | 251 / 258 | 8% | 0.14 | 19 / 230 |
skin | 70% | 30.73 | 1271 / 1809 | 35% | 0.83 | 164 / 472 |
thymus | 86% | 33.56 | 559 / 653 | 18% | 0.28 | 106 / 605 |
spleen | 100% | 519.91 | 241 / 241 | 0% | 0 | 0 / 0 |
pancreas | 51% | 14.80 | 167 / 328 | 47% | 0.96 | 84 / 178 |
peripheral blood | 96% | 2134.21 | 896 / 929 | 0% | 0 | 0 / 0 |
adipose | 95% | 60.09 | 1147 / 1204 | 0% | 0 | 0 / 0 |
uterus | 79% | 29.99 | 135 / 170 | 11% | 0.23 | 49 / 459 |
heart | 88% | 51.57 | 757 / 861 | 0% | 0 | 0 / 0 |
blood vessel | 84% | 37.91 | 1119 / 1335 | 0% | 0 | 0 / 0 |
ovary | 54% | 17.77 | 98 / 180 | 28% | 0.44 | 120 / 430 |
liver | 61% | 19.15 | 137 / 226 | 4% | 0.06 | 15 / 406 |
lymph node | 0% | 0 | 0 / 0 | 52% | 1.04 | 15 / 29 |
tonsil | 0% | 0 | 0 / 0 | 36% | 0.54 | 16 / 45 |
muscle | 26% | 5.30 | 210 / 803 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 4% | 0.04 | 3 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0008360 | Biological process | regulation of cell shape |
GO_0006468 | Biological process | protein phosphorylation |
GO_0032956 | Biological process | regulation of actin cytoskeleton organization |
GO_0015629 | Cellular component | actin cytoskeleton |
GO_0005925 | Cellular component | focal adhesion |
GO_0005515 | Molecular function | protein binding |
GO_0004672 | Molecular function | protein kinase activity |
Gene name | PEAK3 |
Protein name | Protein PEAK3 |
Synonyms | C19orf35 |
Description | FUNCTION: Probable catalytically inactive kinase (Probable). Interacts with CRK-II and antagonizes CRK-II-signaling. Prevents the formation of CRK-II-dependent membrane ruffling and lamellipodia-like extensions . . |
Accessions | Q6ZS72 ENST00000342063.5 |